ANI Pharmaceuticals ANIP Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's treasury stock, shares (in shares)?
- ANI Pharmaceuticals (ANIP) reported treasury stock, shares (in shares) of $881.49K in Q1 2026.
- How has ANI Pharmaceuticals's treasury stock, shares (in shares) changed year-over-year?
- ANI Pharmaceuticals's treasury stock, shares (in shares) increased by 48.7% year-over-year, from $592.96K to $881.49K.
- What is the long-term trend for ANI Pharmaceuticals's treasury stock, shares (in shares)?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's treasury stock, shares (in shares) has grown at a 60.9% compound annual growth rate (CAGR), from $149.03K to $621.3K.